Health Minister Alexandru Rogobete has announced the expansion of the genetic testing program for cancer patients through a draft order currently undergoing a public consultation process. The measure, discussed with representatives of the Ministry of Health’s Oncology Commission and the National Health Insurance House (CNAS), would enable more precise identification of tumor markers and the selection of treatment based on the profile of each tumor.
The draft includes six new categories of cancer: medullary thyroid cancer, cholangiocarcinoma, gastrointestinal stromal tumors (GIST), malignant melanoma, prostate cancer, and squamous cell carcinoma of the head and neck. The proposed tests target the RET, NTRK, FGFR2, IDH1, PDGFRA, BRAF V600, PD-L1, BRCA1, and BRCA2 markers, depending on the condition.
Test results would generally be provided within a maximum of 10 working days. According to the minister, this expansion would facilitate the establishment of a molecular diagnosis, the identification of suitable targeted therapies and immunotherapies, and the adaptation of treatment to the tumor’s biological characteristics.
The new investigations are not yet reimbursed. The draft must go through the public consultation stage, and the estimated date for the start of reimbursement is January 1, 2027. Rogobete thanked the teams from the Ministry of Health and CNAS involved in preparing the document.
Sources
Latest News
11:04
11:00
10:49
10:46
10:42
See more news